This speculation was supported by the studies showing that increased adiponectin level and amelioration of the disease in mice with lupus when treated with PPARγ agonist [81], regardless of the already elevated adiponectin level in these mice. Here, ADIPOQ is linked to systemic lupus erythematosus.